Dr. Stover is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1145 Olentangy River Rd
Columbus, OH 43212Phone+1 614-293-0066Fax+1 614-293-7264
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2015
Vanderbilt University Medical CenterResidency, Internal Medicine, 2008 - 2012
Vanderbilt University School of MedicineClass of 2008
Certifications & Licensure
OH State Medical License 2017 - 2026
MA State Medical License 2012 - 2019
TN State Medical License 2010 - 2013- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 5 citationsDepression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer Survivorship.Annelise A Madison, Rebecca Andridge, Anthony H Kantaras, Megan E Renna, Jeanette M Bennett
Cancers. 2023-09-04 - 199 citationsCDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer.Shawn F. Johnson, Cristina Cruz, Ann Katrin Greifenberg, Sofia Dust, Daniel G. Stover
Cell Reports. 2016-11-22 - 15 citationsMatched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness.Otto Metzger-Filho, Katharine Collier, Sarah Asad, Peter Ansell, Mark A. Watson
NPJ Breast Cancer. 2021-11-11
Journal Articles
- Tumor Fraction in Cell-Free DNA as a Biomarker in Prostate CancerHeather A. Parsons, Atish D. Choudhury, Lauren C. Harshman, Daniel G. Stover, The Journal of Clinical Investigation
Press Mentions
New Hormonal Treatment Orserdu Approved for Metastatic Breast CancerFebruary 13th, 2023- Twitter: Dr Toni Choueiri – FDA Approve Pembrolizumab Top Tweet Q4 2021November 4th, 2021
- De-Escalation of Radiation Therapy in Patients with Stage I, Node-Negative, HER2-Positive Breast CancerMarch 25th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
